NovaBridge Biosciences reported total assets of $231.54M and total liabilities of $30.44M for the quarter ended Jun 2026, up 10.8% year over year. This balance sheet covers 20 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2018 | Sep2019 | Dec2019 | Jun2020 | Sep2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | -4.66M | -5.75M | ||||||||||||||||||
| Receivables - AccuredAcc. Int. Receivables | 0.22M | 0.11M | 0.04M | 1.04M | 0.03M | 0.03M | 0.01M | 0.00M | ||||||||||||
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 229.71M | 239.82M | 161.39M | 220.81M | 435.96M | 718.07M | 672.48M | 551.13M | 554.02M | 451.90M | 325.40M | 297.42M | 151.96M | 79.33M | 68.26M | 53.60M | 165.40M | 228.06M | 210.63M | 190.64M |
| Receivables - NetNet Receivables | 19.69M | 5.17M | 0.08M | |||||||||||||||||
| Receivables - OtherOther Receivables | 1.59M | 3.20M | 37.62M | 1.26M | 43.46M | 1.16M | 1.97M | |||||||||||||
| Receivables | 22.89M | 6.44M | 43.53M | 1.16M | ||||||||||||||||
| Inventory | 4.26M | 10.53M | 4.63M | 0.72M | ||||||||||||||||
| Prepaid Assets | 12.87M | 19.30M | 18.56M | 32.38M | 29.49M | 31.04M | 29.85M | 15.08M | 11.29M | 14.11M | 7.22M | 22.99M | 3.82M | 3.29M | 4.61M | 2.03M | 4.50M | 6.68M | 7.16M | |
| Current Assets | 294.59M | 193.14M | 239.64M | 472.54M | 806.32M | 807.81M | 747.91M | 644.16M | 509.90M | 424.04M | 324.53M | 230.48M | 188.21M | 176.69M | 173.23M | 167.64M | 232.78M | 217.52M | 198.00M | |
| Non-Current Assets | ||||||||||||||||||||
| Construction in Progress | 0.14M | 3.30M | 0.91M | 0.87M | ||||||||||||||||
| Property, Plant & Equipment (Net) | 4.00M | 4.27M | 3.98M | 3.81M | 0.00M | 1.04M | 9.13M | 8.55M | 5.07M | 0.20M | 0.17M | 0.15M | 0.14M | 1.27M | ||||||
| Long-Term Investments | 112.38M | 100.32M | 89.53M | 55.07M | 32.50M | 4.34M | 1.57M | 1.68M | 19.00M | 34.47M | 40.32M | 37.24M | 25.06M | |||||||
| Goodwill | 23.51M | 23.07M | 23.01M | 23.95M | 24.53M | 25.18M | 25.43M | 24.27M | 22.86M | 22.42M | ||||||||||
| Intangibles | 21.53M | 21.12M | 21.07M | 17.97M | 18.17M | 18.59M | 18.72M | 17.81M | 16.72M | 16.34M | 16.40M | |||||||||
| Goodwill & Intangibles | 45.04M | 44.18M | 43.95M | 41.11M | 42.71M | 43.77M | 44.15M | 42.08M | 39.57M | 40.13M | 16.40M | |||||||||
| Other Non-Current Assets | 13.40M | 2.60M | 4.93M | 0.30M | 0.95M | 4.17M | 2.30M | 1.53M | 1.14M | 0.59M | 0.46M | 1.44M | 1.36M | 1.29M | 1.22M | 1.15M | 2.81M | 2.87M | ||
| Non-Current Assets | 49.04M | 53.38M | 50.19M | 157.44M | 122.32M | 144.39M | 188.81M | 215.29M | 220.42M | 62.37M | 252.99M | 23.35M | 44.47M | 35.99M | 35.71M | 39.07M | 44.63M | 43.00M | 33.54M | |
| Assets | 343.63M | 246.53M | 289.98M | 633.04M | 955.73M | 952.21M | 876.08M | 745.22M | 572.77M | 484.29M | 362.91M | 253.83M | 232.68M | 212.68M | 208.94M | 206.71M | 277.41M | 260.52M | 231.54M | |
| Liabilities | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts Payables | 9.79M | 38.81M | 34.40M | 49.83M | 84.58M | 83.04M | 92.80M | 81.74M | 99.35M | 82.08M | 49.69M | 11.26M | 11.02M | 7.53M | 6.92M | 6.49M | 15.22M | 16.82M | 16.82M | |
| Notes Payables | 11.57M | 7.09M | 2.67M | 4.13M | 4.16M | |||||||||||||||
| Payables | 21.36M | 45.91M | 34.31M | 48.88M | 84.58M | 83.04M | 92.80M | 81.74M | 102.01M | 89.26M | 53.85M | 11.26M | 11.02M | 7.53M | 6.92M | 6.49M | 15.22M | 16.82M | 16.82M | |
| Other Accumulated Expenses | 0.97M | 1.16M | 1.18M | 1.22M | 1.53M | 4.80M | 6.35M | 3.37M | 3.77M | 3.04M | 0.74M | 0.75M | 0.11M | 0.83M | 0.85M | 0.87M | 9.18M | 8.88M | ||
| Current Leases | 46.87M | 3.09M | ||||||||||||||||||
| Current Taxes | 7.09M | |||||||||||||||||||
| Current Deferred Revenue | 0.36M | 0.20M | 0.20M | 1.10M | 0.45M | 1.13M | 0.71M | -1.17M | 35.83M | 1.22M | 1.46M | 0.31M | ||||||||
| Curent Deferred Tax Liability | 0.56M | 0.67M | ||||||||||||||||||
| Total Current Liabilities | 50.06M | 83.49M | 35.56M | 51.46M | 86.93M | 85.28M | 97.60M | 88.08M | 106.60M | 91.44M | 57.20M | 1.98M | 11.77M | 8.45M | 7.75M | 7.35M | 16.09M | 26.89M | 25.92M | |
| Non-Current Liabilities | ||||||||||||||||||||
| Convertible Debt | 9.69M | 9.68M | 9.79M | 9.54M | ||||||||||||||||
| Non-Current Deffered Revenue | 0.36M | 0.56M | 0.67M | 35.04M | 35.83M | 37.66M | 36.91M | 40.57M | ||||||||||||
| Preferred Stock Liabilities | 421.65M | 440.42M | ||||||||||||||||||
| Liabilities from Discontinued Operations | -50.98M | |||||||||||||||||||
| Operating Leases | 1.06M | 1.03M | 0.76M | 0.84M | 4.84M | 12.79M | 9.15M | 4.51M | 2.81M | 3.21M | 3.22M | 3.03M | 3.07M | 2.85M | 2.63M | 2.40M | 2.18M | 3.18M | ||
| Other Non-Current Liabilities | 0.81M | 38.81M | 1.33M | 1.24M | 1.35M | 0.96M | 2.34M | 2.08M | 2.39M | 6.76M | 9.68M | 0.51M | 1.33M | |||||||
| Total Non-Current Liabilities | 480.95M | 496.40M | 79.18M | 1.65M | 105.65M | 27.60M | 34.69M | 32.63M | 145.05M | 48.59M | 11.52M | 29.07M | 29.10M | |||||||
| Total Liabilities | 481.77M | 535.21M | 80.39M | 106.63M | 106.61M | 162.92M | 145.64M | 163.63M | 152.04M | 124.28M | 15.34M | 12.95M | 11.52M | 10.60M | 9.97M | 18.50M | 29.58M | 30.44M | ||
| Shareholder's Equity | ||||||||||||||||||||
| Total Debt | 11.57M | 7.09M | 2.67M | 4.28M | 4.16M | |||||||||||||||
| Common Equity | -138.14M | -231.89M | -288.68M | 551.08M | 849.10M | 845.60M | 713.16M | 599.59M | 409.14M | 337.43M | 238.63M | 238.49M | 219.74M | 201.16M | 198.34M | 196.73M | 258.92M | 230.94M | 201.10M | |
| Liabilities and Shareholders Equity | 343.63M | 246.53M | 289.14M | 620.98M | 955.73M | 952.21M | 876.08M | 745.22M | 572.77M | 501.38M | 362.91M | 253.83M | 232.68M | 212.68M | 208.94M | 206.71M | 277.41M | 260.52M | 231.54M | |
| Treasury Shares | 0.23M | 2.35M | 13.55M | 13.24M | 11.33M | 11.14M | 5.36M | -5.04M | ||||||||||||
| Retained Earnings | -146.73M | -353.88M | -451.40M | -305.30M | -480.09M | -681.14M | -806.45M | -964.85M | -1052.91M | -1156.63M | -1256.47M | -1276.98M | -1286.04M | -1289.19M | -1294.69M | -1301.52M | -1332.31M | -1370.18M | ||
| Preferred Shares | 1,306.63M | 1,306.63M | 1,306.63M | 0.13M | 0.13M | 0.02M |
Pull NovaBridge Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NBP", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=NBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();